SDC - SmileDirectClub, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Nashville,
United States
Type: Equity
SDC price evolution
SDC
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $57.99 | $86.25 | $93.12 | $120.18 |
| Short term investments | ||||
| Net receivables | $178.78 | $183.52 | $143.08 | $201.78 |
| Inventory | $35.56 | $40.03 | $44.39 | $44.24 |
| Total current assets | $212.49 | $251.59 | $297.42 | $338.04 |
| Long term investments | ||||
| Property, plant & equipment | $188.39 | $200.56 | $211.23 | $225.32 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $286.22 | $294.02 | $299.64 | $293.76 |
| Total investments | ||||
| Total assets | $498.71 | $545.61 | $597.06 | $631.8 |
| Current liabilities | ||||
| Accounts payable | $35.69 | $34.88 | $30.51 | $36.1 |
| Deferred revenue | $14.91 | $16.84 | $13.65 | $14.51 |
| Short long term debt | $4.22 | |||
| Total current liabilities | $111.73 | $112.24 | $116.8 | $147.78 |
| Long term debt | $876.68 | $874.82 | $849.38 | $805.14 |
| Total noncurrent liabilities | $877.1 | $875.24 | $865.46 | $805.88 |
| Total debt | $876.68 | $874.82 | $865.46 | $809.35 |
| Total liabilities | $988.82 | $987.48 | $485.67 | $953.66 |
| Shareholders' equity | ||||
| Retained earnings | -$420.92 | -$403.14 | -$364.11 | -$359.88 |
| Other shareholder equity | $0.44 | $0.53 | $0.43 | $0.74 |
| Total shareholder equity | $86.53 | $98.56 | $111.4 | $126.47 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $93.12 | $224.86 | $316.72 | $318.46 |
| Short term investments | ||||
| Net receivables | $143.08 | $243.77 | $293.33 | $345.73 |
| Inventory | $44.39 | $40.8 | $29.25 | $18.43 |
| Total current assets | $297.42 | $467.74 | $580.78 | $590.49 |
| Long term investments | ||||
| Property, plant & equipment | $211.23 | $252.13 | $221.17 | $177.54 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $299.64 | $326.82 | $304.01 | $295.16 |
| Total investments | ||||
| Total assets | $597.06 | $794.56 | $884.79 | $885.64 |
| Current liabilities | ||||
| Accounts payable | $30.51 | $19.92 | $36.85 | $52.71 |
| Deferred revenue | $13.65 | $20.26 | $26.62 | $25.43 |
| Short long term debt | $11 | $15.66 | $35.38 | |
| Total current liabilities | $116.8 | $178.24 | $186.54 | $206.86 |
| Long term debt | $849.38 | $750.33 | $420.71 | $173.15 |
| Total noncurrent liabilities | $865.46 | $750.67 | $464.11 | $220.5 |
| Total debt | $865.46 | $761.32 | $436.37 | $208.53 |
| Total liabilities | $485.67 | $928.91 | $650.65 | $427.36 |
| Shareholders' equity | ||||
| Retained earnings | -$364.11 | -$295.32 | -$192.88 | -$114.51 |
| Other shareholder equity | $0.43 | $0.29 | -$0.1 | -$0.27 |
| Total shareholder equity | $111.4 | $171.5 | $308.07 | $333.12 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $101.8 | $119.78 | $86.53 | $106.77 |
| Cost of revenue | $28.88 | $32.89 | $33.75 | $32 |
| Gross Profit | $72.91 | $86.89 | $52.78 | $74.78 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $109.39 | $137.37 | $124.28 | $133.72 |
| Total operating expenses | $117.91 | $146.07 | $117.37 | $138.41 |
| Operating income | -$45 | -$59.18 | -$64.59 | -$63.63 |
| Income from continuing operations | ||||
| EBIT | -$8.76 | -$13.39 | -$15.43 | -$15.57 |
| Income tax expense | $0.49 | $0.32 | -$0.17 | $0.74 |
| Interest expense | $8.53 | $7.71 | $6.59 | $5.36 |
| Net income | ||||
| Net income | -$17.77 | -$21.42 | -$21.84 | -$21.67 |
| Income (for common shares) | -$17.77 | -$21.42 | -$21.84 | -$21.67 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $470.74 | $637.61 | $656.78 | $750.43 |
| Cost of revenue | $142.89 | $177.6 | $206.85 | $178.39 |
| Gross Profit | $327.85 | $460.01 | $449.93 | $572.04 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $569.01 | $714.02 | $634.9 | $1062.31 |
| Total operating expenses | $589.97 | $719.3 | $667.39 | $1062.31 |
| Operating income | -$262.11 | -$259.28 | -$217.46 | -$490.27 |
| Income from continuing operations | ||||
| EBIT | -$69.08 | -$78.02 | -$30.23 | -$96.51 |
| Income tax expense | -$0.64 | $1.27 | $3.12 | $2.27 |
| Interest expense | $17.96 | $23.15 | $45.01 | $15.73 |
| Net income | ||||
| Net income | -$86.4 | -$102.44 | -$78.37 | -$114.51 |
| Income (for common shares) | -$86.4 | -$102.44 | -$78.37 | -$114.51 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Net income | -$17.77 | -$21.42 | -$21.84 | -$21.67 |
| Operating activities | ||||
| Depreciation | $15.52 | $15.87 | $16.79 | $19.11 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.34 | $6.63 | $5.05 | $7.69 |
| Total cash flows from operations | -$17.84 | -$32.58 | -$51.47 | -$27.6 |
| Investing activities | ||||
| Capital expenditures | -$10.24 | -$8.04 | -$11.83 | -$7.3 |
| Investments | ||||
| Total cash flows from investing | -$10.24 | -$8.04 | -$11.83 | -$7.3 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.2 | $0.16 | $2.41 | -$0.56 |
| Net borrowings | $8 | $60.33 | -$1.97 | |
| Total cash flows from financing | -$0.05 | $8.44 | $61.44 | -$3.32 |
| Effect of exchange rate | -$0.13 | $0.04 | $0.07 | $0.14 |
| Change in cash and equivalents | -$28.26 | -$32.14 | -$1.78 | -$38.08 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$86.4 | -$102.44 | -$78.37 | -$114.51 |
| Operating activities | ||||
| Depreciation | $74.39 | $70.11 | $56.39 | $27.34 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $26.61 | $44.63 | $44.9 | $350.12 |
| Total cash flows from operations | -$158.17 | -$141.52 | -$83.57 | -$333.19 |
| Investing activities | ||||
| Capital expenditures | -$52 | -$106.57 | -$97.14 | -$106.36 |
| Investments | ||||
| Total cash flows from investing | -$52 | -$106.57 | -$97.14 | -$106.36 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.06 | -$9 | -$11.06 | $494.84 |
| Net borrowings | $108.47 | $297.64 | $200.23 | -$39.87 |
| Total cash flows from financing | $103.45 | $155.72 | $178.97 | $444.08 |
| Effect of exchange rate | $0.26 | $0.51 | ||
| Change in cash and equivalents | -$106.46 | -$91.86 | -$1.73 | $4.53 |
News
Fundamentals
| Market cap | $8.57M |
|---|---|
| Enterprise value | $827.25M |
| Shares outstanding | 402.23M |
| Revenue | $414.88M |
|---|---|
| EBITDA | $14.14M |
| EBIT | -$53.15M |
| Net Income | -$82.71M |
| Revenue Q/Q | -19.08% |
| Revenue Y/Y | -23.37% |
| P/E ratio | -0.10 |
|---|---|
| EV/Sales | 1.99 |
| EV/EBITDA | 58.49 |
| EV/EBIT | -15.57 |
| P/S ratio | 0.02 |
| P/B ratio | 0.10 |
| Book/Share | 0.21 |
| Cash/Share | 0.14 |
| EPS | -$0.21 |
|---|---|
| ROA | -14.55% |
| ROE | -78.22% |
| Debt/Equity | 4.36 |
|---|---|
| Net debt/EBITDA | 65.81 |
| Current ratio | 1.90 |
| Quick ratio | 1.58 |